BNTX logo

BioNTech SE (BNTX) EBIT

Annual EBIT:

-$695.96M-$1.68B(-171.08%)
December 31, 2024

Summary

  • As of today, BNTX annual earnings before interest & taxes is -$695.96 million, with the most recent change of -$1.68 billion (-171.08%) on December 31, 2024.
  • During the last 3 years, BNTX annual EBIT has fallen by -$21.54 billion (-103.34%).
  • BNTX annual EBIT is now -103.34% below its all-time high of $20.84 billion, reached on December 31, 2021.

Performance

BNTX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Quarterly EBIT:

$743.43M+$1.36B(+219.88%)
September 30, 2025

Summary

  • As of today, BNTX quarterly earnings before interest & taxes is $743.43 million, with the most recent change of +$1.36 billion (+219.88%) on September 30, 2025.
  • Over the past year, BNTX quarterly EBIT has increased by +$342.35 million (+85.36%).
  • BNTX quarterly EBIT is now -86.10% below its all-time high of $5.35 billion, reached on September 30, 2021.

Performance

BNTX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM EBIT:

-$236.50M+$342.35M(+59.14%)
September 30, 2025

Summary

  • As of today, BNTX TTM earnings before interest & taxes is -$236.50 million, with the most recent change of +$342.35 million (+59.14%) on September 30, 2025.
  • Over the past year, BNTX TTM EBIT has increased by +$30.10 million (+11.29%).
  • BNTX TTM EBIT is now -101.14% below its all-time high of $20.80 billion, reached on March 31, 2022.

Performance

BNTX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

BNTX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-171.1%+85.4%+11.3%
3Y3 Years-103.3%-66.6%-101.6%
5Y5 Years-238.8%+426.7%+47.1%

BNTX EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-103.3%at low-78.9%+198.7%-101.6%+66.8%
5Y5-Year-103.3%at low-86.1%+198.7%-101.1%+66.8%
All-TimeAll-Time-103.3%at low-86.1%+198.7%-101.1%+66.8%

BNTX EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$743.43M(+219.9%)
-$236.50M(+59.1%)
Jun 2025
-
-$620.14M(-7.7%)
-$578.85M(+18.7%)
Mar 2025
-
-$575.91M(-366.5%)
-$711.76M(-3.0%)
Dec 2024
-$695.96M(-171.1%)
$216.11M(-46.1%)
-$691.11M(-159.2%)
Sep 2024
-
$401.08M(+153.3%)
-$266.60M(+54.4%)
Jun 2024
-
-$753.04M(-35.6%)
-$584.24M(-51.5%)
Mar 2024
-
-$555.27M(-186.7%)
-$385.60M(-141.1%)
Dec 2023
$979.17M(-93.9%)
$640.63M(+667.8%)
$937.25M(-75.4%)
Sep 2023
-
$83.44M(+115.0%)
$3.81B(-36.0%)
Jun 2023
-
-$554.40M(-172.2%)
$5.96B(-30.1%)
Mar 2023
-
$767.58M(-78.2%)
$8.52B(-34.5%)
Dec 2022
$15.97B(-23.4%)
$3.52B(+57.9%)
$13.01B(-11.3%)
Sep 2022
-
$2.23B(+11.1%)
$14.67B(-17.5%)
Jun 2022
-
$2.01B(-61.9%)
$17.79B(-14.5%)
Mar 2022
-
$5.26B(+1.6%)
$20.80B(+19.5%)
DateAnnualQuarterlyTTM
Dec 2021
$20.84B(+6958.7%)
$5.18B(-3.2%)
$17.41B(+42.2%)
Sep 2021
-
$5.35B(+6.6%)
$12.24B(+83.6%)
Jun 2021
-
$5.02B(+168.5%)
$6.67B(+327.9%)
Mar 2021
-
$1.87B(>+9900.0%)
$1.56B(+513.4%)
Dec 2020
-$303.92M(-47.9%)
$5.57M(+102.4%)
-$376.82M(+15.7%)
Sep 2020
-
-$227.56M(-155.2%)
-$446.95M(-77.2%)
Jun 2020
-
-$89.16M(-35.8%)
-$252.28M(-16.6%)
Mar 2020
-
-$65.67M(-1.7%)
-$216.41M(-10.2%)
Dec 2019
-$205.43M(-197.5%)
-$64.55M(-96.3%)
-$196.47M(-47.6%)
Sep 2019
-
-$32.89M(+38.3%)
-$133.11M(-6.5%)
Jun 2019
-
-$53.30M(-16.5%)
-$124.97M(-74.4%)
Mar 2019
-
-$45.73M(-3738.9%)
-$71.67M(-176.3%)
Dec 2018
-$69.05M(+3.3%)
-$1.19M(+95.2%)
-$25.94M(-4.8%)
Sep 2018
-
-$24.75M
-$24.75M
Dec 2017
-$71.44M
-
-

FAQ

  • What is BioNTech SE annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for BioNTech SE?
  • What is BioNTech SE annual EBIT year-on-year change?
  • What is BioNTech SE quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for BioNTech SE?
  • What is BioNTech SE quarterly EBIT year-on-year change?
  • What is BioNTech SE TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for BioNTech SE?
  • What is BioNTech SE TTM EBIT year-on-year change?

What is BioNTech SE annual earnings before interest & taxes?

The current annual EBIT of BNTX is -$695.96M

What is the all-time high annual EBIT for BioNTech SE?

BioNTech SE all-time high annual earnings before interest & taxes is $20.84B

What is BioNTech SE annual EBIT year-on-year change?

Over the past year, BNTX annual earnings before interest & taxes has changed by -$1.68B (-171.08%)

What is BioNTech SE quarterly earnings before interest & taxes?

The current quarterly EBIT of BNTX is $743.43M

What is the all-time high quarterly EBIT for BioNTech SE?

BioNTech SE all-time high quarterly earnings before interest & taxes is $5.35B

What is BioNTech SE quarterly EBIT year-on-year change?

Over the past year, BNTX quarterly earnings before interest & taxes has changed by +$342.35M (+85.36%)

What is BioNTech SE TTM earnings before interest & taxes?

The current TTM EBIT of BNTX is -$236.50M

What is the all-time high TTM EBIT for BioNTech SE?

BioNTech SE all-time high TTM earnings before interest & taxes is $20.80B

What is BioNTech SE TTM EBIT year-on-year change?

Over the past year, BNTX TTM earnings before interest & taxes has changed by +$30.10M (+11.29%)
On this page